Medicus Pharma (NASDAQ:MDCX) said it will focus future internally sponsored clinical development of SkinJect exclusively on Gorlin syndrome patients with multiple basal cell carcinoma lesions and will ...

MaaT Pharma Announces Upcoming Pre-IND Meeting with the FDA and Advances MaaT034 Toward Clinical Development in Solid Tumors ...

On September 18, 2026, ten departments, including China's Ministry of Industry and Information Technology, jointly ...

Medicus Pharma Ltd. (MDCX) has outlined a revised development strategy that makes CD228V, its second-generation antibody-drug ...

Partnerships in healthcare have never been more important. Through collaboration, industry specialists are increasingly bringing cutting-edge medical innovations and life-changing treatments to ...

LGM Pharma’s Expanded Contract Development and Manufacturing Organization (CDMO) Capabilities Will Enable Customers to Accelerate and Optimize the New Product Pathway from Early Development Through ...

Conclave has become a meeting ground for India’s formulation R&D community. Scientists, innovators, and industry leaders ...

Royalty Pharma plc (NASDAQ:RPRX) said it has entered into a research and development co-funding agreement with Johnson & Johnson (NYSE:JNJ) valued at $500 million to support the development of ...

Hovione, a pharmaceutical CDMO, opened 89 Twin Rivers, a 31,000-square-foot facility at its East Windsor campus on Sept. 15.

The pharmaceutical industry historically has been well known for being risk averse. But the rapid response to Covid-19, particularly the development of vaccines to minimize the effects of the virus ...

On July 28, 2023, the United States Food and Drug Administration (FDA) approved ReVive, an opioid reversal medication manufactured by Harm Reduction Therapeutics, a nonprofit pharmaceutical company.